Sterile Active Pharmaceutical Ingredients Market Forecast, Trend Analysis & Competition Tracking - Global Market Insights 2019 to 2029

Published on : Feb-2020 | List of Tables : 30 | List of Figures : 58 | No. of Pages : 170 | Report Code : FACT1702MR |

Growing Expenditure on Biopharmaceutical Production Driving Sterile Active Pharmaceutical Ingredients Market Growth

Introduction of new drugs for rare indications, rising prevalence of chronic diseases, and growing ageing population have increased the consumption of pharmaceuticals, which has boosted the pharmaceutical expenditure, globally. According to OECD, Global spending on pharmaceuticals was US$ 1,120.6 Bn in 2015 and is expected to increase at a CAGR of 7.1% during 2016 - 2030. Various pharmaceutical and biotechnology companies are focusing on expanding their geographical footprint to increase pharmaceutical production capacity. For instance, in January 2019, Fujifilm announced plans to invest approximately US$ 90Mn to boost its overall production capacity by expanding its production facility at North Carolina. Growing pharmaceutical production and increasing pharmaceutical spending are expected to propel growth of the global sterile active pharmaceutical ingredients market. By value, China held the largest share in 2018 accounting for ~79% of the market. By form, aqueous segment captured the largest share in terms of in 2029 and is projected to show an upward trend through 2029.

global sterile active pharmaceutical ingredients market

For answers to all the possible questions required to gauge the performance of the sterile active pharmaceutical ingredients market, get in touch with our expert analyst

Rapid Shift from in-house Sterile Active Pharmaceutical Ingredients Production to Outsourced Production

Pharmaceutical companies are rapidly shifting from in-house manufacturing to outsourcing of manufacturing operations. North America shows balance in in-house to outsourcing production of sterile active pharmaceutical ingredients. Approximately, 50% of the big pharmaceutical companies prefer in-house production of patented API and outsourcing of dosage form manufacturing. However, companies do not rely on sole producers but partner with various CMOs for manufacturing of finished dosage forms. With a prolific rise in outsourcing of sterile active pharmaceutical ingredients, CMOs are expanding fill and finish capacity for sterile products. As can be evidenced in diagram below, North America on back of aforementioned factors held a major chunk of market share in 2019, closely followed by South Asia which is also poised to exhibit a staggering growth of ~8% through 2029. South Asia’s prolific growth can be attributed to presence of key API manufacturers in countries such as India. Additionally, the region will exhibit high growth on back of increased manufacturing of generic drugs.

sterile active pharmaceutical ingredients market share analysis

For more such actionable insights on the potential of the sterile active pharmaceutical ingredients market, request report sample here

Acquisition and Partnership Key Strategies in Sterile Active Pharmaceutical Ingredients Market

Manufacturers are focusing on expansion of product lines in the sterile active pharmaceutical ingredients segment owing to growing demand for parenteral drugs, biologics, and ophthalmic solutions. Key market stakeholders are adopting acquisition and merger strategies for expansion of production capabilities. For instance, in September 2018, Aurobindo Pharma USA Inc. acquired commercial operations and three manufacturing facilities in the U.S from Sandoz Inc., USA. Also, manufactures are centering towards a strategic partnership with contract manufacturing organization and pharmaceutical companies to access advance manufacturing technologies for sterile products. In February 2017, Sanofi and Lonza entered a strategic partnership to operate large-scale mammalian cell culture facility for monoclonal antibody production in Visp, Switzerland.

Increasing Research & Development Investments in Pharmaceutical Industry

The healthcare industry is heavily dependent on developing new treatment options for the treatment of various chronic diseases such as cancer, HIV, arthritis, cardiovascular diseases, etc. Increasing healthcare R&D expenditure, further improves the chances of possibility of breakthrough treatments. As per the data from European Federation of Pharmaceutical Industries and Associations (EFPIA) and (Pharmaceutical Research and Manufacturers of America) PhRMA, annual pharmaceutical R&D expenditures expanded at 2.5% p.a. in Europe as compared to 3.3% p.a. in the U.S. during 2011-2016. Rapidly growing pharmaceutical expenditure is anticipated to result in new molecule discovery that favors the demand for sterile active pharmaceutical ingredients.

Sterile Active Pharmaceutical Ingredients Market - Scope of the Report

Fact.MR recently published a market study on the global market for sterile active pharmaceutical ingredients. The study provides detailed assessment on the key market dynamics, including drivers, trends, opportunities restraints, and detailed information about the sterile active pharmaceutical ingredients market structure. The market study presents exclusive information about how the sterile active pharmaceutical ingredients market will grow during the forecast period (2019-2029).

Key indicators of market growth, which include Year-on-Year (Y-o-Y) growth of the market, and compounded annual growth rate (CAGR) are explained in Fact.MR’s study in a comprehensive manner. This information can help readers understand the quantitative growth prospects of the sterile active pharmaceutical ingredients market during the forecast period.

The study is relevant for stakeholders in the sterile active pharmaceutical ingredients market, including sterile active pharmaceutical ingredients manufacturers, suppliers, distributors, and investors, and can help them in developing appropriate strategies to grow in the market. Stakeholders in the sterile active pharmaceutical ingredients market, investors, industry experts, researchers, and journalists, as well as business researchers can leverage the information and data presented in Fact.MR’s study.

The study also includes statistics as well as facts related to macro as well as microeconomic factors that are impacting developments in the market. It also offers actionable insights based on the future trends in the sterile active pharmaceutical ingredients market. Furthermore, small businesses and new entrants in the sterile active pharmaceutical ingredients market too can make use of the information presented in this study, based on which, they can make appropriate business decisions to gain momentum in the market.

Key Segments of the Sterile Active Pharmaceutical Ingredients Market

Fact.MR’s study on the sterile active pharmaceutical ingredients market offers information divided into four important segments— product type, form and region. This report offers comprehensive data and information about the important market dynamics and growth parameters associated with these categories.

Product Type

Form

Region

  • Monoclonal Antibodies
  • Immunoglobulin
  • Cytokines
  • Insulin
  • Peptide Hormones
  • Blood Factors
  • Peptide Antibiotics
  • Vaccines
  • Small Molecule Antibiotics
  • Highly Potent Active Pharmaceutical Ingredients (HPAPI)
  • Others

 

  • Aqueous
  • Non-Aqueous Liquid
  • Dry Powder
  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • Middle East & Africa

Key Questions Answered in Fact.MR’s Sterile Active Pharmaceutical Ingredients Market Report

  • Which regions will continue to remain the most profitable regional markets for sterile active pharmaceutical ingredients market players?
  • Which factors will induce a change in the demand for sterile active pharmaceutical ingredients manufacturers during the assessment period?
  • How will changing trends impact the sterile active pharmaceutical ingredients market?
  • How can market players capture the low-hanging opportunities in the sterile active pharmaceutical ingredients market in developed regions?
  • Which companies are leading the sterile active pharmaceutical ingredients market?
  • What are the winning strategies of stakeholders in the sterile active pharmaceutical ingredients market to upscale their position in this landscape?

Sterile Active Pharmaceutical Ingredients Market: Research Methodology

In Fact.MR’s study, a unique research methodology is utilized to conduct extensive research on the growth of the sterile active pharmaceutical ingredients market, and reach conclusions on the future growth parameters of the market. This research methodology is a combination of primary and secondary research, which helps analysts ensure accuracy and reliability of conclusions.

Secondary resources referred to analysts during the production of the sterile active pharmaceutical ingredients market study include statistics from government organizations, trade journals, white papers, and internal and external proprietary databases. Analysts have interviewed senior managers, product portfolio managers, CEOs, VPs, marketing/product managers, and market intelligence managers, who contributed to the development of this report as a primary resource.

Comprehensive information acquired from primary resources and secondary resources acts as a validation from companies in the sterile active pharmaceutical ingredients market, and makes Fact.MR’s projection on the growth prospects of the sterile active pharmaceutical ingredients market more accurate and reliable.

1. Executive Summary

    1.1. Global Market Outlook

    1.2. Demand Side Trends

    1.3. Supply Side Trends

    1.4. Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage / Taxonomy

    2.2. Market Definition / Scope / Limitations

3. Key Market Trends

    3.1. Key Trends Impacting the Market

    3.2. Product Innovation / Technology Trends

4. Market Background

    4.1. Macro-Economic Factors

    4.2. Forecast Factors - Relevance & Impact

    4.3. Market Dynamics

        4.3.1. Drivers

        4.3.2. Restraints

        4.3.3. Opportunity Analysis

    4.4. Parent Market Analysis

5. Global Sterile Active Pharmaceutical Ingredients Market Analysis 2014-2018 and Forecast 2019-2029, by Product Type 

    5.1. Introduction / Key Findings

    5.2. Historical Market Size (US$ Mn) Analysis By Product Type, 2014-2018

    5.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Product Type, 2019-2029

        5.3.1. Monoclonal Antibody

        5.3.2. Immunoglobulin

        5.3.3. Cytokines

        5.3.4. Insulin

        5.3.5. Peptide Hormones

        5.3.6. Blood Factors

        5.3.7. Peptide Antibiotics

        5.3.8. Vaccines

        5.3.9. Small Molecule Antibiotics

        5.3.10. Highly Potent Active Pharmaceutical Ingredients (HPAPI)

        5.3.11. Others

    5.4. Market Attractiveness Analysis By Product Type

6. Global Sterile Active Pharmaceutical Ingredients Market Analysis 2014-2018 and Forecast 2019-2029, by Form

    6.1. Introduction / Key Findings

    6.2. Historical Market Size (US$ Mn) Analysis By Form, 2014-2018

    6.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Form, 2019-2029

        6.3.1. Aqueous 

        6.3.2. Non-aqueous liquid

        6.3.3. Dry powder

    6.4. Market Attractiveness Analysis By Form

7. Global Sterile Active Pharmaceutical Ingredients Market Analysis 2014-2018 and Forecast 2019-2029, by Region

    7.1. Introduction

    7.2. Historical Market Size (US$ Mn) Analysis By Region, 2014-2018

    7.3. Current Market Size (US$ Mn) Analysis and Forecast By Region, 2019-2029

        7.3.1. North America

        7.3.2. Latin America

        7.3.3. Europe

        7.3.4. East Asia

        7.3.5. South Asia

        7.3.6. Oceania

        7.3.7. Middle East and Africa (MEA)

    7.4. Market Attractiveness Analysis By Region

8. North America Sterile Active Pharmaceutical Ingredients Market Analysis 2014-2018 and Forecast 2019-2029

    8.1. Introduction

    8.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2014-2018

    8.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2019-2029

        8.3.1.  By Country

            8.3.1.1. U.S.

            8.3.1.2. Canada

        8.3.2. By Product Type

        8.3.3. By Form

    8.4. Market Attractiveness Analysis

        8.4.1. By Country

        8.4.2. By Product Type

        8.4.3. By Form

9. Latin America Sterile Active Pharmaceutical Ingredients Market Analysis 2014-2018 and Forecast 2019-2029

    9.1. Introduction

    9.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2014-2018

    9.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2019-2029

        9.3.1.  By Country

            9.3.1.1. Brazil

            9.3.1.2. Mexico

            9.3.1.3. Rest of Latin America

        9.3.2. By Product Type

        9.3.3. By Form

    9.4. Market Attractiveness Analysis

        9.4.1. By Country

        9.4.2. By Product Type

        9.4.3. By Form

10. Europe Sterile Active Pharmaceutical Ingredients Market Analysis 2014-2018 and Forecast 2019-2029

    10.1. Introduction

    10.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2014-2018

    10.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2019-2029

        10.3.1.  By Country

            10.3.1.1. Germany

            10.3.1.2. Italy

            10.3.1.3. France

            10.3.1.4. U.K.

            10.3.1.5. Spain

            10.3.1.6. Russia

            10.3.1.7. Rest of Europe

        10.3.2. By Product Type

        10.3.3. By Form

    10.4. Market Attractiveness Analysis

        10.4.1. By Country

        10.4.2. By Product Type

        10.4.3. By Form

11. South Asia Sterile Active Pharmaceutical Ingredients Market Analysis 2014-2018 and Forecast 2019-2029

    11.1. Introduction

    11.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2014-2018

    11.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2019-2029

        11.3.1.  By Country

            11.3.1.1. India

            11.3.1.2. Thailand

            11.3.1.3. Indonesia

            11.3.1.4. Malaysia

            11.3.1.5. Rest of South Asia

        11.3.2. By Product Type

        11.3.3. By Form

    11.4. Market Attractiveness Analysis

        11.4.1. By Country

        11.4.2. By Product Type

        11.4.3. By Form

12. East Asia Sterile Active Pharmaceutical Ingredients Market Analysis 2014-2018 and Forecast 2019-2029

    12.1. Introduction

    12.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2014-2018

    12.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2019-2029

        12.3.1.  By Country

            12.3.1.1. China

            12.3.1.2. Japan

            12.3.1.3. South Korea

        12.3.2. By Product Type

        12.3.3. By Form

    12.4. Market Attractiveness Analysis

        12.4.1. By Country

        12.4.2. By Product Type

        12.4.3. By Form

13. Oceania Sterile Active Pharmaceutical Ingredients Market Analysis 2014-2018 and Forecast 2019-2029

    13.1. Introduction

    13.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2014-2018

    13.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2019-2029

        13.3.1.  By Country

            13.3.1.1. Australia

            13.3.1.2. New Zealand

        13.3.2. By Product Type

        13.3.3. By Form

    13.4. Market Attractiveness Analysis

        13.4.1. By Country

        13.4.2. By Product Type

        13.4.3. By Form

14. Middle East and Africa Sterile Active Pharmaceutical Ingredients Market Analysis 2014-2018 and Forecast 2019-2029

    14.1. Introduction

    14.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2014-2018

    14.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2019-2029

        14.3.1.  By Country

            14.3.1.1. GCC Countries

            14.3.1.2. Turkey

            14.3.1.3. Northern Africa

            14.3.1.4. South Africa

            14.3.1.5. Rest of Middle East and Africa

        14.3.2. By Product Type

        14.3.3. By Form

    14.4. Market Attractiveness Analysis

        14.4.1. By Country

        14.4.2. By Product Type

        14.4.3. By Form

15. Emerging Countries Sterile Active Pharmaceutical Ingredients Market Analysis 2014-2018 and Forecast 2019-2029

    15.1. Introduction

        15.1.1. Market Value Proportion Analysis, By Key Countries

        15.1.2. Global Vs. Country Growth Comparison

    15.2. China Sterile Active Pharmaceutical Ingredients Market Analysis

        15.2.1. Introduction

        15.2.2. Market Value Proportion Analysis by Market Taxonomy

        15.2.3. Market Value (US$ Mn) Analysis and Forecast by Market Taxonomy

            15.2.3.1. By Product Type

            15.2.3.2. By Form

    15.3. Mexico Sterile Active Pharmaceutical Ingredients Market Analysis

        15.3.1. Introduction

        15.3.2. Market Value Proportion Analysis by Market Taxonomy

        15.3.3. Market Value (US$ Mn) Analysis and Forecast by Market Taxonomy

            15.3.3.1. By Product Type

            15.3.3.2. By Form

    15.4. India Sterile Active Pharmaceutical Ingredients Market Analysis

        15.4.1. Introduction

        15.4.2. Market Value Proportion Analysis by Market Taxonomy

        15.4.3. Market Value (US$ Mn) Analysis and Forecast by Market Taxonomy

            15.4.3.1. By Product Type

            15.4.3.2. By Form

16. Market Structure Analysis

17. Competition Analysis

    17.1. Competition Dashboard

    17.2. Competition Deep Dive 

        17.2.1. Aurobindo Pharma Limited 

            17.2.1.1. Overview

            17.2.1.2. Sterile API Portfolio

            17.2.1.3. Key Financials

            17.2.1.4. Key Developments  

            17.2.1.5. Analyst Commentary

        17.2.2. Teva Pharmaceutical Industries Ltd. 

            17.2.2.1. Overview

            17.2.2.2. Sterile API Portfolio

            17.2.2.3. Key Financials

            17.2.2.4. Key Developments  

            17.2.2.5. Analyst Commentary

        17.2.3. Corden Pharma GmbH 

            17.2.3.1. Overview

            17.2.3.2. Sterile API Portfolio

            17.2.3.3. Key Financials

            17.2.3.4. Key Developments  

            17.2.3.5. Analyst Commentary

        17.2.4. Dalton Pharma Services 

            17.2.4.1. Overview

            17.2.4.2. Sterile API Portfolio

            17.2.4.3. Key Financials

            17.2.4.4. Key Developments  

            17.2.4.5. Analyst Commentary

        17.2.5. Pfizer Inc.

            17.2.5.1. Overview

            17.2.5.2. Sterile API Portfolio

            17.2.5.3. Key Financials

            17.2.5.4. Key Developments  

            17.2.5.5. Analyst Commentary

        17.2.6. Sun Pharmaceutical Industries Ltd. 

            17.2.6.1. Overview

            17.2.6.2. Sterile API Portfolio

            17.2.6.3. Key Financials

            17.2.6.4. Key Developments  

            17.2.6.5. Analyst Commentary

        17.2.7. Lonza Group 

            17.2.7.1. Overview

            17.2.7.2. Sterile API Portfolio

            17.2.7.3. Key Financials

            17.2.7.4. Key Developments  

            17.2.7.5. Analyst Commentary

        17.2.8. Albany Molecular Research Inc. 

            17.2.8.1. Overview

            17.2.8.2. Sterile API Portfolio

            17.2.8.3. Key Financials

            17.2.8.4. Key Developments  

            17.2.8.5. Analyst Commentary

        17.2.9. Sanofi S.A 

            17.2.9.1. Overview

            17.2.9.2. Sterile API Portfolio

            17.2.9.3. Key Financials

            17.2.9.4. Key Developments  

            17.2.9.5. Analyst Commentary

        17.2.10. Dr. Reddy’s Laboratories Ltd

            17.2.10.1. Overview

            17.2.10.2. Sterile API Portfolio

            17.2.10.3. Key Financials

            17.2.10.4. Key Developments  

            17.2.10.5. Analyst Commentary

18. Assumptions and Acronyms Used

19. Research Methodology

Fact.MR offers custom research services that help clients to get specific research solutions

We are committed towards customer satisfaction and quality service.


Our Clients

Malaysian Cocoa Board
Dunlop International Europe Ltd
Roland Berger
Superior Essex
Commscope
Deloitte

Fact.MR in Media

Sterile Active Pharmaceutical Ingredients Market Forecast, Trend Analysis & Competition Tracking - Global Market Insights 2019 to 2029